Loading video...

Video Failed to Load

Go Home

Lung cancer e-learning for HCPs Topic: the evolving TROP2-directed ADC landscape in metastatic NSCLC + strategies to optimise the treatment experience Endorsed by ICAN, International Cancer Advocacy Network, Exon 20 Group, a multistakeholder organization & Biomarker Collaborative Supported by an Independent Educational Grant from AstraZeneca 📹

lung_connect's profile picture

LUNG CONNECT powered by COR2ED

1,024 subscribers

4,932,060 views • 1 month ago •via X (Twitter)

Science & TechnologyEducationHealth & Wellness
LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

Are ADCs the next therapeutic options for pts w/ pretreated HR+/HER2- (IHC 0) metastatic breast cancer who have developed an endocrine resistance? Find out as you follow a pt journey in this case-based video Endorsed by ICAN, International Cancer Advocacy Network Biomarker Collaborative GRASP & Exon 20 Group, a multistakeholder organization Supported by an Independent Educational Grant from AstraZeneca.
9:15

Are ADCs the next therapeutic options for pts w/ pretreated HR+/HER2- (IHC 0) metastatic breast cancer who have developed an endocrine resistance? Find out as you follow a pt journey in this case-based video Endorsed by ICAN, International Cancer Advocacy Network Biomarker Collaborative GRASP & Exon 20 Group, a multistakeholder organization Supported by an Independent Educational Grant from AstraZeneca.

BREAST CANCER CONNECT

1,019,784 views • 11 months ago

Pre-analytical phase challenges & biomarker testing in HER2+ metastatic breast cancer From Prof. Gary Tse, Dr Carlos Barrios, & Oncology Brothers Highlights in this video 📹 >> Endorsed by Biomarker Collaborative Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
5:46

Pre-analytical phase challenges & biomarker testing in HER2+ metastatic breast cancer From Prof. Gary Tse, Dr Carlos Barrios, & Oncology Brothers Highlights in this video 📹 >> Endorsed by Biomarker Collaborative Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

BREAST CANCER CONNECT powered by COR2ED

20,487,530 views • 1 month ago

Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer
4:51

Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

COR2ED

5,214,734 views • 5 months ago

Managing ADC toxicities in HER2+ metastatic breast cancer - spotlight on nausea & vomiting Nausea/vomiting are common AEs associated with ADCs, particularly T-DXd, along with fatigue ILD, while less common, is an AE of special interest How can you manage N/V and more in clinical practice? Get step-by-step guidance from Dr Sara Tolaney Endorsed by ICAN, International Cancer Advocacy Network Supported by an Independent Educational Grant from AstraZeneca
6:39

Managing ADC toxicities in HER2+ metastatic breast cancer - spotlight on nausea & vomiting Nausea/vomiting are common AEs associated with ADCs, particularly T-DXd, along with fatigue ILD, while less common, is an AE of special interest How can you manage N/V and more in clinical practice? Get step-by-step guidance from Dr Sara Tolaney Endorsed by ICAN, International Cancer Advocacy Network Supported by an Independent Educational Grant from AstraZeneca

BREAST CANCER CONNECT powered by COR2ED

528,125 views • 9 months ago

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer
1:07

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

2,703,909 views • 1 month ago

GI CONNECT podcast episode Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) Dr. Shubham Pant & Prof. Efrat Dotan MD discuss chemotherapy strategies that matter Conversation topics include: - Efficacy & safety profiles - Relevance of mode of delivery - Cause of toxicities - Strategies to manage side effects 📹 Highlights video in this post Endorsed by ICAN, International Cancer Advocacy Network Digestive Cancers Europe The National Pancreas Foundation PanCAN Supported by an Independent Educational Grant from Ipsen USA
4:31

GI CONNECT podcast episode Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) Dr. Shubham Pant & Prof. Efrat Dotan MD discuss chemotherapy strategies that matter Conversation topics include: - Efficacy & safety profiles - Relevance of mode of delivery - Cause of toxicities - Strategies to manage side effects 📹 Highlights video in this post Endorsed by ICAN, International Cancer Advocacy Network Digestive Cancers Europe The National Pancreas Foundation PanCAN Supported by an Independent Educational Grant from Ipsen USA

GI CONNECT powered by COR2ED

1,202,878 views • 10 months ago

Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED
5:30

Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED

COR2ED

114,711 views • 9 months ago

ADCs in HER2+ metastatic breast cancer: management of adverse events Get step-by-step strategies to support effective management of T-DXd–related adverse events in HER2+ mBC > N/V > Fatigue > Interstitial lung disease (rare but critical) From Prof. Shaheenah Dawood, Dr Sara Tolaney, Prof. Javier Cortes MD PhD, Carla Whitbread, Dr Grazyna Suchodolska & Prof. Giuseppe Curigliano Endorsed by the European Oncology Nursing Society (@cancernurseEU) and Europa Donna Supported by an Independent Educational Grant from AstraZeneca
3:41

ADCs in HER2+ metastatic breast cancer: management of adverse events Get step-by-step strategies to support effective management of T-DXd–related adverse events in HER2+ mBC > N/V > Fatigue > Interstitial lung disease (rare but critical) From Prof. Shaheenah Dawood, Dr Sara Tolaney, Prof. Javier Cortes MD PhD, Carla Whitbread, Dr Grazyna Suchodolska & Prof. Giuseppe Curigliano Endorsed by the European Oncology Nursing Society (@cancernurseEU) and Europa Donna Supported by an Independent Educational Grant from AstraZeneca

BREAST CANCER CONNECT powered by COR2ED

7,264,152 views • 5 months ago

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim
5:45

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim

COR2ED

757,945 views • 7 months ago

When should early treatment intensification w/ PARPi + ARPI combination be considered for mCRPC patients? 📺 Find out in this patient case video >> You’ll also discover the SHARE Communication Framework to use with your pts in clinical practice SHARE is made up of 5 key elements: S – Success criteria & aim of treatment H – How the treatments work A – Advantages/disadvantages of each Tx option R – Risks & effective management of side effects E – Expectations for Tx success Part 1 of the highlights video in this post ~ Endorsed by Urobel & ZERO Prostate Cancer Supported by an Independent Educational Grant from AstraZeneca
5:33

When should early treatment intensification w/ PARPi + ARPI combination be considered for mCRPC patients? 📺 Find out in this patient case video >> You’ll also discover the SHARE Communication Framework to use with your pts in clinical practice SHARE is made up of 5 key elements: S – Success criteria & aim of treatment H – How the treatments work A – Advantages/disadvantages of each Tx option R – Risks & effective management of side effects E – Expectations for Tx success Part 1 of the highlights video in this post ~ Endorsed by Urobel & ZERO Prostate Cancer Supported by an Independent Educational Grant from AstraZeneca

GU CONNECT powered by COR2ED

164,512 views • 6 months ago

🧬 What do HCPs need to know about current treatment options for advanced/recurrent EndometrialCancer? An animated MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.
7:36

🧬 What do HCPs need to know about current treatment options for advanced/recurrent EndometrialCancer? An animated MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.

OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED

240,514 views • 1 year ago

🧬 What do HCPs need to know about current treatment options for advanced/recurrent #EndometrialCancer? An animated #MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme. #Oncology #GynecologicCancer
7:36

🧬 What do HCPs need to know about current treatment options for advanced/recurrent #EndometrialCancer? An animated #MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme. #Oncology #GynecologicCancer

OBSTETRICS & GYNECOLOGY CONNECT

462,512 views • 1 year ago

COVID vaccines linked to a 27% INCREASE in overall cancer risk, South Korean study finds. “There’s a one in a thousand chance that this result arose by chance,” Dr. John Campbell noted. Children’s Health Defense reports: The study used data from 2021-2023 for over 8.4 million people in South Korea’s National Health Insurance Service database. The sample was split into two groups based on vaccination status. The vaccinated sample was further split into booster and non-booster groups. Researchers tracked the patients for one year. The vaccinated group was tracked following vaccination. The results showed a statistically significant higher risk of cancer in the vaccinated group, including: Overall cancer: 27% higher risk Breast cancer: 20% higher risk Colorectal cancer: 28% higher risk Gastric cancer: 34% higher risk Lung cancer: 53% higher risk Prostate cancer: 69% higher risk Thyroid cancer: 35% higher risk
1:19

COVID vaccines linked to a 27% INCREASE in overall cancer risk, South Korean study finds. “There’s a one in a thousand chance that this result arose by chance,” Dr. John Campbell noted. Children’s Health Defense reports: The study used data from 2021-2023 for over 8.4 million people in South Korea’s National Health Insurance Service database. The sample was split into two groups based on vaccination status. The vaccinated sample was further split into booster and non-booster groups. Researchers tracked the patients for one year. The vaccinated group was tracked following vaccination. The results showed a statistically significant higher risk of cancer in the vaccinated group, including: Overall cancer: 27% higher risk Breast cancer: 20% higher risk Colorectal cancer: 28% higher risk Gastric cancer: 34% higher risk Lung cancer: 53% higher risk Prostate cancer: 69% higher risk Thyroid cancer: 35% higher risk

The Vigilant Fox 🦊

934,237 views • 10 months ago

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?
3:46

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,291 views • 1 year ago

A Physicians Survey Revealed 88.3% Of Doctors Would Refuse Chemotherapy For Their Own Cancer Treatment. The 5 Year Chemo Survival Rate Is Only 2.1%, Yet Most Oncologists Only Offer 'Standard Of Care' To Patients. Dr Seyfried Would Choose The Protocol With Ivermectin & Fasting. American Society of Clinical Oncology (ASCO) Board of Directors has data that oncologists THEMSELVES would not take chemotherapy for cancer even though they advise chemo & radiation as the only 'approved' treatment to their patients. MacKillop & colleagues found that a survey of Canadian doctors who treat lung cancer, only 16% would want chemotherapy for their own treatment if they had a cancer diagnosis. Lind & colleagues interviewed teaching oncologists in Boston & found that only 27% would take chemo for lung cancer. "The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies" cites...The overall contribution of curative & adjuvant cytotoxic chemotherapy to 5-year survival in adults is only 2.3% in Australia & 2.1% in the USA. Cancer treatment is a multi-billion dollar industry. Most oncologists believe that cancer is genetic, but cancer is a metabolic disease. Doctors don’t study nutrition or metabolic therapy & don't even know that chemotherapy historically was a 'weapon of war' mustard gas. Banned from use in war because it is cytotoxic & too inhumane, even against war enemies. The system profits more from lifelong chemo & radiation than natural intervention. Chemotherapy is not the answer to heal the body of cancer. GKI Glucose Ketone Index & Cancer Eradication Based On Otto Warburg's Groundbreaking Research: Cancer cells are metabolically inflexible & cannot use ketone bodies for energy when glucose is limited, unlike healthy cells. A low GKI is achieved by restricting carbohydrates, which lowers blood glucose & increases ketone production. This starves cancer cells of glucose while providing normal cells with an alternative energy source. Research shows a low glucose environment promotes our Natural Killer (NK) cells & T-cells to become even stronger which are crucial for killing cancer. Chemotherapy & radiation actually kills our NK Natural Killer Cells allowing cancer to return even stronger than before conventional treatment. 15 expert physicians & oncologists have published...'Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol.' This is the step by step protocol of fasting, high fat ketogenic diet (eliminating glucose) & using ivermectin, fenbendazole & supportive nutrients with lifestyle changes for cancer treatment remission. This protocol, along with cited research is linked in the replies. Have you used non traditional methods to reverse cancer? Is your cancer in remission thanks to fasting, ivermectin or other alternative protocols? Share and repost this message to increase awareness. It is essential for the public to be informed. Follow my page for further motivational and educational content.
0:59

A Physicians Survey Revealed 88.3% Of Doctors Would Refuse Chemotherapy For Their Own Cancer Treatment. The 5 Year Chemo Survival Rate Is Only 2.1%, Yet Most Oncologists Only Offer 'Standard Of Care' To Patients. Dr Seyfried Would Choose The Protocol With Ivermectin & Fasting. American Society of Clinical Oncology (ASCO) Board of Directors has data that oncologists THEMSELVES would not take chemotherapy for cancer even though they advise chemo & radiation as the only 'approved' treatment to their patients. MacKillop & colleagues found that a survey of Canadian doctors who treat lung cancer, only 16% would want chemotherapy for their own treatment if they had a cancer diagnosis. Lind & colleagues interviewed teaching oncologists in Boston & found that only 27% would take chemo for lung cancer. "The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies" cites...The overall contribution of curative & adjuvant cytotoxic chemotherapy to 5-year survival in adults is only 2.3% in Australia & 2.1% in the USA. Cancer treatment is a multi-billion dollar industry. Most oncologists believe that cancer is genetic, but cancer is a metabolic disease. Doctors don’t study nutrition or metabolic therapy & don't even know that chemotherapy historically was a 'weapon of war' mustard gas. Banned from use in war because it is cytotoxic & too inhumane, even against war enemies. The system profits more from lifelong chemo & radiation than natural intervention. Chemotherapy is not the answer to heal the body of cancer. GKI Glucose Ketone Index & Cancer Eradication Based On Otto Warburg's Groundbreaking Research: Cancer cells are metabolically inflexible & cannot use ketone bodies for energy when glucose is limited, unlike healthy cells. A low GKI is achieved by restricting carbohydrates, which lowers blood glucose & increases ketone production. This starves cancer cells of glucose while providing normal cells with an alternative energy source. Research shows a low glucose environment promotes our Natural Killer (NK) cells & T-cells to become even stronger which are crucial for killing cancer. Chemotherapy & radiation actually kills our NK Natural Killer Cells allowing cancer to return even stronger than before conventional treatment. 15 expert physicians & oncologists have published...'Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol.' This is the step by step protocol of fasting, high fat ketogenic diet (eliminating glucose) & using ivermectin, fenbendazole & supportive nutrients with lifestyle changes for cancer treatment remission. This protocol, along with cited research is linked in the replies. Have you used non traditional methods to reverse cancer? Is your cancer in remission thanks to fasting, ivermectin or other alternative protocols? Share and repost this message to increase awareness. It is essential for the public to be informed. Follow my page for further motivational and educational content.

Joe Tippens

47,858 views • 5 months ago

A Physicians Survey Revealed 88.3% Of Doctors Would Refuse Chemotherapy For Their Own Cancer Treatment. The 5 Year Chemo Survival Rate Is Only 2.1%, Yet Most Oncologists Only Offer 'Standard Of Care' To Patients. Dr Seyfried Would Choose The Protocol With Ivermectin & Fasting. American Society of Clinical Oncology (ASCO) Board of Directors has data that oncologists THEMSELVES would not take chemotherapy for cancer even though they advise chemo & radiation as the only 'approved' treatment to their patients. MacKillop & colleagues found that a survey of Canadian doctors who treat lung cancer, only 16% would want chemotherapy for their own treatment if they had a cancer diagnosis. Lind & colleagues interviewed teaching oncologists in Boston & found that only 27% would take chemo for lung cancer. "The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies" cites...The overall contribution of curative & adjuvant cytotoxic chemotherapy to 5-year survival in adults is only 2.3% in Australia & 2.1% in the USA. Cancer treatment is a multi-billion dollar industry. Most oncologists believe that cancer is genetic, but cancer is a metabolic disease. Doctors don’t study nutrition or metabolic therapy & don't even know that chemotherapy historically was a 'weapon of war' mustard gas. Banned from use in war because it is cytotoxic & too inhumane, even against war enemies. The system profits more from lifelong chemo & radiation than natural intervention. Chemotherapy is not the answer to heal the body of cancer. GKI Glucose Ketone Index & Cancer Eradication Based On Otto Warburg's Groundbreaking Research: Cancer cells are metabolically inflexible & cannot use ketone bodies for energy when glucose is limited, unlike healthy cells. A low GKI is achieved by restricting carbohydrates, which lowers blood glucose & increases ketone production. This starves cancer cells of glucose while providing normal cells with an alternative energy source. Research shows a low glucose environment promotes our Natural Killer (NK) cells & T-cells to become even stronger which are crucial for killing cancer. Chemotherapy & radiation actually kills our NK Natural Killer Cells allowing cancer to return even stronger than before conventional treatment. 15 expert physicians & oncologists have published...'Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol.' This is the step by step protocol of fasting, high fat ketogenic diet (eliminating glucose) & using ivermectin, fenbendazole & supportive nutrients with lifestyle changes for cancer treatment remission. This protocol, along with cited research is linked in the replies. Have you used non traditional methods to reverse cancer? Is your cancer in remission thanks to fasting, ivermectin or other alternative protocols?
1:25

A Physicians Survey Revealed 88.3% Of Doctors Would Refuse Chemotherapy For Their Own Cancer Treatment. The 5 Year Chemo Survival Rate Is Only 2.1%, Yet Most Oncologists Only Offer 'Standard Of Care' To Patients. Dr Seyfried Would Choose The Protocol With Ivermectin & Fasting. American Society of Clinical Oncology (ASCO) Board of Directors has data that oncologists THEMSELVES would not take chemotherapy for cancer even though they advise chemo & radiation as the only 'approved' treatment to their patients. MacKillop & colleagues found that a survey of Canadian doctors who treat lung cancer, only 16% would want chemotherapy for their own treatment if they had a cancer diagnosis. Lind & colleagues interviewed teaching oncologists in Boston & found that only 27% would take chemo for lung cancer. "The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies" cites...The overall contribution of curative & adjuvant cytotoxic chemotherapy to 5-year survival in adults is only 2.3% in Australia & 2.1% in the USA. Cancer treatment is a multi-billion dollar industry. Most oncologists believe that cancer is genetic, but cancer is a metabolic disease. Doctors don’t study nutrition or metabolic therapy & don't even know that chemotherapy historically was a 'weapon of war' mustard gas. Banned from use in war because it is cytotoxic & too inhumane, even against war enemies. The system profits more from lifelong chemo & radiation than natural intervention. Chemotherapy is not the answer to heal the body of cancer. GKI Glucose Ketone Index & Cancer Eradication Based On Otto Warburg's Groundbreaking Research: Cancer cells are metabolically inflexible & cannot use ketone bodies for energy when glucose is limited, unlike healthy cells. A low GKI is achieved by restricting carbohydrates, which lowers blood glucose & increases ketone production. This starves cancer cells of glucose while providing normal cells with an alternative energy source. Research shows a low glucose environment promotes our Natural Killer (NK) cells & T-cells to become even stronger which are crucial for killing cancer. Chemotherapy & radiation actually kills our NK Natural Killer Cells allowing cancer to return even stronger than before conventional treatment. 15 expert physicians & oncologists have published...'Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol.' This is the step by step protocol of fasting, high fat ketogenic diet (eliminating glucose) & using ivermectin, fenbendazole & supportive nutrients with lifestyle changes for cancer treatment remission. This protocol, along with cited research is linked in the replies. Have you used non traditional methods to reverse cancer? Is your cancer in remission thanks to fasting, ivermectin or other alternative protocols?

Valerie Anne Smith

262,596 views • 8 months ago

NEW EPISODE: Dr Thomas Seyfried, Pierre Kory MD Unite for Metabolic Oncology - The Manhattan Project for Cancer I'm joined by Thomas N. Seyfried and Pierre Kory, MD MPA for an exciting discussion on why cancer isn't a genetic disease, the untold damage from standardized treatment, a new paradigm in oncology, treatment with repurposed drugs, what needs to happen at the regulatory scene, and more. Timestamps 0:00 Preview 0:56 Introduction 4:54 Cancer isn't a genetic disease 7:52 Why cancer rates have dropped 9:56 Resistance to paradigm shifts 16:50 Toxic standard treatments 20:37 How the shift is occurring 23:55 The diet factor 29:11 Trial design and prioritization 31:12 Everything comes down to energy 34:50 Repurposed drugs 38:48 Glucose ketone index 47:47 Adverse effects? 48:40 How fast your tumor can grow 49:07 Cancer stem cells 1:00:00 Patient testimonies 1:01:20 Why antibiotics take out cancer cells? 1:04:19 Cancer should looked at as a systemic disorder 1:04:49 Final thoughts
1:10:19

NEW EPISODE: Dr Thomas Seyfried, Pierre Kory MD Unite for Metabolic Oncology - The Manhattan Project for Cancer I'm joined by Thomas N. Seyfried and Pierre Kory, MD MPA for an exciting discussion on why cancer isn't a genetic disease, the untold damage from standardized treatment, a new paradigm in oncology, treatment with repurposed drugs, what needs to happen at the regulatory scene, and more. Timestamps 0:00 Preview 0:56 Introduction 4:54 Cancer isn't a genetic disease 7:52 Why cancer rates have dropped 9:56 Resistance to paradigm shifts 16:50 Toxic standard treatments 20:37 How the shift is occurring 23:55 The diet factor 29:11 Trial design and prioritization 31:12 Everything comes down to energy 34:50 Repurposed drugs 38:48 Glucose ketone index 47:47 Adverse effects? 48:40 How fast your tumor can grow 49:07 Cancer stem cells 1:00:00 Patient testimonies 1:01:20 Why antibiotics take out cancer cells? 1:04:19 Cancer should looked at as a systemic disorder 1:04:49 Final thoughts

David Gornoski

91,192 views • 1 year ago